A review of the system's log file was conducted, which confirmed that there were no malfunctions observed during the procedure.No system malfunctions were observed.A review of the device history record (dhr) for the aquabeam system, lot number 18c00639, was conducted, which confirmed that there were no nonconformances generated during the manufacturing process of this system.The review indicated that the system met all required specifications upon release for distribution.A review for similar events was conducted on the aquabeam robotic system, lot number 18c00639, which confirmed that there were no other similar events reported on this system.The aquabeam robotic system's instructions for use (ifu), ifu0101, rev.C, states the following: 3.Contraindications: do not use the aquabeam robotic system in patients who do not meet the indication for the system's intended use.In addition, do not use the system in the following: unable to safely stop anticoagulants or antiplatelet agents perioperatively.4.3.Warnings: procedure: as with any surgical urologic procedure, potential perioperative risks of the aquablation procedure include: bleeding.The system was not returned for investigation of this event.Bleeding is a potential risk of the aquablation procedure.Per the ifu, the patient must be able to safely stop anticoagulant agents perioperatively.Based on the review of the log file, dhr, and ifu, the event is considered not to be device related.
|
A male patient underwent an aquablation procedure.The patient had a medical history of being on levonox and pradaxa anticoagulant medications (per the manufacturer's instructions for use, patients must be able to safely stop anticoagulant agents before surgery).Twenty-four hours post discharge, the patient was readmitted due to bleeding (per manufacturer's instructions for use, bleeding is a potential risk of the aquablation procedure).The patient received a blood transfusion (number of units unknown) and was reported to be in good condition with no further clinical sequela.No malfunction of the aquabeam system was reported.Additional information was received that the patient was put back on levonox and pradaxa approximately after 12 hours post-surgery.
|